Vaxcell-Bio Therapeutics Inc. logo

Vaxcell-Bio Therapeutics Inc. (323990)

Market Open
10 Aug, 06:30
KRX SM KRX SM
KRX SM KRX SM Primary
₩
4,435. 00
+265
+6.3549%
₩
241.01B Market Cap
- P/E Ratio
- Div Yield
128,353 Volume
- Eps
₩ 4,170
Previous Close
Add Transaction
Day Range
4,210 4,435
Year Range
3,350 11,520
Want to track 323990 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free

Summary

323990 trading today higher at ₩4,435, an increase of 6.3549% from yesterday's close, completing a monthly decrease of -13.2094% or -₩675. Over the past 12 months, 323990 stock lost -55.2923%.
323990 is not paying dividends to its shareholders.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Vaxcell-Bio Therapeutics Inc. has completed 2 stock splits, with the recent split occurring on Nov 10, 2023.
The company's stock is traded on one exchange.

323990 Chart

No Data

People also search for

207940
Samsung Biologics Co., Ltd.
₩ 1,588,000
+1.211%
068270
Celltrion Inc.
₩ 204,500
+1.7413%
196170
ALTEOGEN Inc.
₩ 340,500
-2.1552%
326030
Sk Biopharmaceuticals Co., Ltd.
₩ 90,600
+2.1421%
298380
ABL Bio Inc.
₩ 92,300
-1.3889%

Vaxcell-Bio Therapeutics Inc. (323990) FAQ

What is the stock price today?

The current price is ₩4,435.00.

On which exchange is it traded?

Vaxcell-Bio Therapeutics Inc. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 323990.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 241.01B.

Has Vaxcell-Bio Therapeutics Inc. ever had a stock split?

Vaxcell-Bio Therapeutics Inc. had 2 splits and the recent split was on Nov 10, 2023.

Vaxcell-Bio Therapeutics Inc. Profile

Biotechnology Industry
Healthcare Sector
- CEO
KRX SM Exchange
KR7323990002 ISIN
KR Country
- Employees
- Last Dividend
30 Dec 2020 Last Split
- IPO Date

Overview

Vaxcell-Bio Therapeutics Co., Ltd. operates within the biotechnology sphere, primarily focusing on the development and commercialization of cancer immune cell therapy products. Since its inception in 2010, the company has strived to advance the field of cancer treatment through innovative therapeutic solutions. Based in Hwasun-eup, South Korea, Vaxcell-Bio Therapeutics Co., Ltd. leverages cutting-edge research and development to create products designed to enhance the efficacy of cancer treatments, thereby improving patient outcomes.

Products and Services

  • Cancer Immune Cell Therapy Products

    Vaxcell-Bio Therapeutics Co., Ltd. offers a range of products aimed at harnessing the body's immune system to fight cancer. These products focus on activating and enhancing the cancer-fighting capabilities of immune cells, thereby providing a novel approach to cancer treatment. The specifics of each product, such as the type of immune cells targeted and the cancer types they are designed to treat, reflect the company’s commitment to addressing a wide spectrum of oncological challenges through immunotherapy.

Contact Information

Address: 12-55, Sandan-gil
Phone: 82 6 1373 0046
Download app banner
Blog Affiliate Program About Terms Privacy Help Contact Us
2026 © Marketlog. All Rights Reserved.
Play store app banner Play store app banner dark App store app banner App store app banner dark